A detailed history of Federated Hermes, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 423,269 shares of NTRA stock, worth $45.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
423,269
Previous 527,200 19.71%
Holding current value
$45.1 Million
Previous $33 Million 17.23%
% of portfolio
0.09%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$59.21 - $92.9 $6.15 Million - $9.66 Million
-103,931 Reduced 19.71%
423,269 $38.7 Million
Q4 2023

Jan 31, 2024

SELL
$37.55 - $62.64 $218,691 - $364,815
-5,824 Reduced 1.09%
527,200 $33 Million
Q3 2023

Nov 13, 2023

BUY
$43.4 - $62.52 $4.11 Million - $5.92 Million
94,761 Added 21.62%
533,024 $23.6 Million
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $1.98 Million - $2.33 Million
42,162 Added 10.64%
438,263 $21.3 Million
Q1 2023

May 08, 2023

BUY
$36.57 - $58.29 $6.23 Million - $9.93 Million
170,301 Added 75.42%
396,101 $22 Million
Q4 2022

Feb 13, 2023

BUY
$34.17 - $47.91 $3.42 Million - $4.79 Million
100,000 Added 79.49%
225,800 $9.07 Million
Q2 2022

Aug 15, 2022

SELL
$28.13 - $44.54 $24.2 Million - $38.3 Million
-859,634 Reduced 87.23%
125,800 $4.46 Million
Q1 2022

May 13, 2022

SELL
$30.32 - $91.33 $29.4 Million - $88.4 Million
-968,387 Reduced 49.56%
985,434 $40.1 Million
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $37.8 Million - $52.2 Million
438,497 Added 28.94%
1,953,821 $182 Million
Q3 2021

Nov 15, 2021

BUY
$100.17 - $126.36 $50 Million - $63.1 Million
499,488 Added 49.17%
1,515,324 $169 Million
Q2 2021

Aug 16, 2021

SELL
$86.05 - $119.72 $6.2 Million - $8.63 Million
-72,054 Reduced 6.62%
1,015,836 $115 Million
Q1 2021

May 13, 2021

SELL
$91.47 - $124.36 $1.25 Million - $1.71 Million
-13,714 Reduced 1.24%
1,087,890 $110 Million
Q4 2020

Feb 12, 2021

BUY
$66.66 - $111.74 $909,175 - $1.52 Million
13,639 Added 1.25%
1,101,604 $110 Million
Q3 2020

Nov 12, 2020

BUY
$45.89 - $72.67 $3.42 Million - $5.41 Million
74,465 Added 7.35%
1,087,965 $78.6 Million
Q2 2020

Aug 13, 2020

SELL
$26.36 - $49.86 $764 - $1,445
-29 Reduced -0.0%
1,013,500 $50.5 Million
Q1 2020

May 13, 2020

SELL
$17.27 - $40.17 $6.16 Million - $14.3 Million
-356,575 Reduced 26.03%
1,013,529 $30.3 Million
Q4 2019

Feb 14, 2020

BUY
$32.1 - $40.4 $17.3 Million - $21.8 Million
539,206 Added 64.89%
1,370,104 $46.2 Million
Q3 2019

Nov 14, 2019

BUY
$25.38 - $34.89 $10.1 Million - $13.9 Million
399,186 Added 92.47%
830,898 $27.3 Million
Q2 2019

Aug 14, 2019

BUY
$17.75 - $27.58 $7.07 Million - $11 Million
398,418 Added 1196.67%
431,712 $11.9 Million
Q3 2018

Nov 13, 2018

BUY
$18.82 - $28.96 $626,593 - $964,194
33,294 New
33,294 $797,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.